HIV/AIDS

Expert reports about HIV/AIDS

Also known as Dolutegravir

THE SAFETY OF DOLUTEGRAVIR (TIVICAY) DURING PREGNANCY OR BREASTFEEDING

 

THIS MEDICATION CAN CAUSE HARM TO YOUR BABY: Recent data suggest dolutegravir may be associated with an increased risk of brain and spinal cord defects with exposure just before pregnancy or during the first trimester. Breastfeeding is generally not recommended in HIV positive women.


TO READ THE FULL REPORT

Join Pregistry to access the information you need at no cost to you

Join Pregistry